PS3-14 A high throughput screen of TLR3-IRF3 signaling pathway modulators identifies several anti-pyschotic drugs as TLR modulators1This work was supported in part by Scientist Development Grant from American Heart Association (SNS), CA06220 from National Cancer Institute (GCS), AI082673 from National Institute of Allergy and Infectious Diseases (SNS), and University of Pittsburgh Cancer Institute Start up funds (SNS).1